Treatment of idiopathic hypertension with guanabenz-mefruside
Tomasi, A.M.; Pirani, R.; Masoni, C.
Minerva Cardioangiologica 32(5): 339-344
1984
ISSN/ISBN: 0026-4725 PMID: 6382059 Document Number: 234634
Document emailed within 1 workday
Related Documents
Walson, P.D.; Rath, A.; Kilbourne, K.; Deitch, M.W. 1984: Guanabenz for adolescent hypertension Pediatric Pharmacology 4(1): 1-6Rosendorff, C. 1982: Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension South African Medical Journal 62(13): 435-437
Jagenburg, R.; Landahl, S.; Steen, B. 1977: Blood pressure and serum potassium during 6 months of mefruside treatment Lakartidningen 74(27-28): 2509-2511
Landmark, K.; Kravik, S. 1979: Use of the anti-G suit in the treatment of idiopathic orthostatic hypertension Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 99(30): 1530-1531
Hlavácová, P.; Vlková, E. 2009: Benefit of the surgical treatment of the idiopathic intracranial hypertension--a case report Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 65(5): 195-198
Noda, M.; Sonoda, Y.; Takemoto, M.; Kira, R. 2017: Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide No to Hattatsu 49(3): 207-210
Barbagallo, M.; Vitaliti, G.; Greco, F.; Pavone, P.; Matin, N.; Panta, G.; Lubrano, R.; Falsaperla, R. 2017: Idiopathic intracranial hypertension in a paediatric population: a retrospective observational study on epidemiology, symptoms and treatment Journal of Biological Regulators and Homeostatic Agents 31(1): 195-200
Morínigo, F.; Cezimbra, J.P. 1970: Clinical findings on the use of mefruside Hospital (Rio de Janeiro) 77(6): 1965-1970
Batyraliev, T.A.; Makhmutkhodzhaev, S.A.; Ekence, E.; Pataraia, S.A.; Pershukov, I.V.; Sidorenko, B.A.; Preobrezhenskiĭ, D.V. 2007: Pulmonary hypertension and right ventricular failure. Part VIII. Diagnosis, course, and prognosis of primary (idiopathic) pulmonary arterial hypertension Kardiologiia 47(3): 69-78
Schlossmann, K.; Pütter, J. 1973: Studies on the formation of the lactone and acid form of the main metabolite of mefruside Arzneimittel-Forschung 23(2): 255-262
Strandhoy, J.W.; Morris, M.; Buckalew, V.M. 1982: Renal effects of the antihypertensive, guanabenz, in the dog Journal of Pharmacology and Experimental Therapeutics 221(2): 347-352
Lebrec, D. 1989: Idiopathic portal hypertension Gastroenterologie Clinique et Biologique 13(10): 761-762
González-Hernández, A.; Fabre-Pi, O.; Díaz-Nicolás, S.; López-Fernández, J.C.; López-Veloso, C.; Jiménez-Mateos, A. 2009: Headache in idiopathic intracranial hypertension Revista de Neurologia 49(1): 17-20
Sakamoto, H.; Inoue, K.; Murata, T.; Kohno, S.; Ohata, K. 1982: Studies on the antinociceptive activity of guanabenz, with particular reference to clonidine and morphine Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 79(2): 85-92
Sztrymf, B.; Yaïci, A.; Jaïs, X.; Sitbon, O.; Simonneau, G.; Humbert, M. 2005: Idiopathic pulmonary hypertension: what did we learn from genes? Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 22(Suppl 1): S91-100
Klimova, N.F. 1978: Idiopathic myelofibrosis occurring with portal hypertension Problemy Gematologii i Perelivaniia Krovi 23(9): 22-26
Chulakova, T.I. 2005: New predictors of idiopathic pulmonary arterial hypertension Likars'ka Sprava 8: 29-33
Chawla, Y.K.; Bhushnurmath, S.R.; Dilawari, J.B. 1987: Cruveilhier-Baumgarten syndrome in idiopathic portal hypertension American Journal of Gastroenterology 82(12): 1336-1337
Maxwell, A.; Holman, T.; Novak, T. 2020: Idiopathic Pulmonary Arterial Hypertension Unmasked by Pregnancy Acute Medicine 19(4): 240-243
Mendenhall, C.L.; Sherman, J.; Chedid, A. 1974: Intermittent idiopathic portal hypertension. A case report Gastroenterology 67(1): 142-148